Enhancing Adherence in Breast Cancer Treatment with CDK4/6 Inhibitors

This Panel Discussion presented by Prof. Angelica Nogueira-Rodrigues and moderated by Prof. Lucia Del Mastro focused on the importance of treatment adherence in breast cancer patients using CDK 4/6 inhibitors, discussing factors influencing adherence, barriers, and strategies to improve it.

Target Audience

Healthcare Professionals

Learning Objectives

  • Understand the impact of treatment adherence on patient outcomes and survival in breast cancer management.
  • Identify strategies and resources, including patient education and healthcare support, to improve adherence with CDK4/6 inhibitors.
  • Recognize the impact of breast cancer treatment on patients' quality of life and the long-term consequences of the diagnosis and its treatment.
  • Understand the importance of patient education and its impact on patient adherence.

This activity is supported by an educational grant from Eli Lilly.

Course summary

Course opens: 
07/22/2025
Course expires: 
09/30/2031
Cost:
$0.00
Rating: 
0
Angélica Nogueira-Rodrigues, MD, PhD

Angélica Nogueira-Rodrigues, MD, PhD

Professor and Researcher at UFMG (Federal University of Minas Gerais)

Professor Lucia Del Mastro

Professor Lucia Del Mastro

Director of the Clinical Oncology unit since 2021 and Coordinator of the Breast Unit since 2017 at Ospedale Policlinico San Martino, Genova Italy, Lucia Del Mastro is Full Professor of Oncology and Director of the Postgraduate School of Oncology at University of Genova, Italy

Price

Cost:
$0.00
Please login or register to take this course.